José Domingo
Pedreira Andrade
Hospital Universitario San Cecilio
Granada, EspañaPublications in collaboration with researchers from Hospital Universitario San Cecilio (9)
2015
-
Dual treatment with lopinavir-ritonavir plus lamivudine versus triple treatment with lopinavir-ritonavir plus lamivudine or emtricitabine and a second nucleos(t)ide reverse transcriptase inhibitor for maintenance of HIV-1 viral suppression (OLE): A randomised, open-label, non-inferiority trial
The Lancet Infectious Diseases, Vol. 15, Núm. 7, pp. 785-792
2013
-
Rilpivirine resistance mutations in HIV patients failing non-nucleoside reverse transcriptase inhibitor-based therapies
AIDS, Vol. 27, Núm. 1, pp. 81-85
2012
2008
-
Didanosine, lamivudine, and efavirenz versus zidovudine, lamivudine, and efavirenz for the initial treatment of hiv type 1 infection: Final analysis (48 weeks) of a prospective, randomized, noninferiority clinical trial, GESIDA 3903
Clinical Infectious Diseases, Vol. 47, Núm. 8, pp. 1083-1092
-
Low rate of adverse hepatic events associated with fosamprenavir/ritonavir-based antiretroviral regimens
HIV Clinical Trials, Vol. 9, Núm. 5, pp. 309-313
2007
-
Assessing self-reported adherence to HIV therapy by questionnaire: The SERAD (Self-Reported Adherence) study
AIDS Research and Human Retroviruses, Vol. 23, Núm. 10, pp. 1166-1175
2005
-
Antiretroviral recommendations may influence the rate of transmission of drug-resistant HIV type 1
Clinical Infectious Diseases, Vol. 41, Núm. 2, pp. 227-232
-
Impact of drug resistance genotypes on CD4+ counts and plasma viremia in heavily antiretroviral-experienced HIV-infected patients
Journal of Medical Virology, Vol. 77, Núm. 1, pp. 23-28
2004
-
Consensus conference on chronic viral hepatitis and HIV infection: Updated Spanish recommendations
Journal of Viral Hepatitis